B Marchant

923 total citations
15 papers, 709 citations indexed

About

B Marchant is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Complementary and alternative medicine. According to data from OpenAlex, B Marchant has authored 15 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 3 papers in Surgery and 3 papers in Complementary and alternative medicine. Recurrent topics in B Marchant's work include Acute Myocardial Infarction Research (5 papers), Heart Rate Variability and Autonomic Control (4 papers) and Cardiovascular and exercise physiology (3 papers). B Marchant is often cited by papers focused on Acute Myocardial Infarction Research (5 papers), Heart Rate Variability and Autonomic Control (4 papers) and Cardiovascular and exercise physiology (3 papers). B Marchant collaborates with scholars based in United Kingdom and United States. B Marchant's co-authors include Paul Wilkinson, Kulasegaram Ranjadayalan, Adam Timmis, A Timmis, Jeremy Sayer, Chris Grundy, P Kopelman, Susan M. Ray, Piet H. van der Graaf and Jaap W. Mandema and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Heart and PubMed.

In The Last Decade

B Marchant

14 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Marchant United Kingdom 11 247 163 108 85 82 15 709
James D. Neaton United States 8 587 2.4× 46 0.3× 57 0.5× 132 1.6× 81 1.0× 8 1.5k
Carla Fornari Italy 15 144 0.6× 38 0.2× 54 0.5× 53 0.6× 86 1.0× 68 752
J Urquhart Netherlands 10 119 0.5× 49 0.3× 87 0.8× 28 0.3× 10 0.1× 21 621
T Lundman Sweden 22 739 3.0× 29 0.2× 112 1.0× 72 0.8× 60 0.7× 59 1.3k
William C. Maier United States 12 76 0.3× 81 0.5× 106 1.0× 438 5.2× 110 1.3× 22 1.3k
Jane Masoli United Kingdom 16 200 0.8× 30 0.2× 69 0.6× 116 1.4× 80 1.0× 37 1.2k
Nicholas G. D. Masca United Kingdom 8 316 1.3× 18 0.1× 47 0.4× 29 0.3× 21 0.3× 11 555
Mariapaola Lanti Italy 24 692 2.8× 26 0.2× 102 0.9× 180 2.1× 92 1.1× 60 1.4k
Mark E. Sutter United States 17 41 0.2× 40 0.2× 107 1.0× 104 1.2× 33 0.4× 47 1.1k
Stefania Spila Alegiani Italy 17 142 0.6× 17 0.1× 82 0.8× 79 0.9× 52 0.6× 58 969

Countries citing papers authored by B Marchant

Since Specialization
Citations

This map shows the geographic impact of B Marchant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Marchant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Marchant more than expected).

Fields of papers citing papers by B Marchant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Marchant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Marchant. The network helps show where B Marchant may publish in the future.

Co-authorship network of co-authors of B Marchant

This figure shows the co-authorship network connecting the top 25 collaborators of B Marchant. A scholar is included among the top collaborators of B Marchant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Marchant. B Marchant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Milligan, Peter A., B Marchant, Steven W. Martin, et al.. (2013). Model-Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development. Clinical Pharmacology & Therapeutics. 93(6). 502–514. 174 indexed citations
2.
Sayer, Jeremy, Paul Wilkinson, Kulasegaram Ranjadayalan, et al.. (1997). Attenuation or absence of circadian and seasonal rhythms of acute myocardial infarction.. Heart. 77(4). 325–329. 72 indexed citations
3.
Wilkinson, Paul, Jeremy Sayer, Chris Grundy, et al.. (1996). Comparison of case fatality in south Asian and white patients after acute myocardial infarction: observational study. BMJ. 312(7042). 1330–1333. 109 indexed citations
4.
Wilkinson, Paul, Robert Stevenson, Kulasegaram Ranjadayalan, et al.. (1995). Early discharge after acute myocardial infarction: risks and benefits.. Heart. 74(1). 71–75. 13 indexed citations
6.
Marchant, B, et al.. (1993). Benefits and risks of thrombolytic, anticoagulant and antiplatelet therapies in atrial fibrillation.. PubMed. 49(3). 186–90.
7.
Ranjadayalan, Kulasegaram, et al.. (1993). Assessment of Holter ST monitoring for risk stratification in patients with acute myocardial infarction treated by thrombolysis.. Heart. 70(3). 233–240. 11 indexed citations
11.
Ranjadayalan, Kulasegaram, et al.. (1993). Reassessment of treadmill stress testing for risk stratification in patients with acute myocardial infarction treated by thrombolysis.. Heart. 70(5). 415–420. 37 indexed citations
12.
13.
Ranjadayalan, Kulasegaram, et al.. (1991). Aging, autonomic function, and the perception of angina.. Heart. 66(1). 15–18. 18 indexed citations
14.
Sigurðarson, Sigurður, et al.. (1991). Epidemiology of scrapie in Iceland and experience with control measures.. 233–242. 37 indexed citations
15.
Marchant, B, et al.. (1989). Flumazenil causing convulsions and ventricular tachycardia.. BMJ. 299(6703). 860.2–860. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026